Patients | Comparators | p-value | |
---|---|---|---|
Age, years, mean (SD) | 68.0 (16.3) | 62.8 (12.7) | 0.200 |
Male gender, n (%) | 32 (55.2) | 9 (45.0) | 0.450 |
Dialysis vintage, months, median (range) | 33.5 (1–320) | 66.5 (5–335) | 0.168 |
Charlson’s comorbidity Index, mean (SD) | 4.82 (1.85) | 5.75 (2.53) | 0.085 |
Frailty score, mean (SD) | 3.65 (2.19) | 3.35 (1.53) | 0.568 |
Anti-SARS-CoV-2 vaccination, n (%) | 44 (74.6) | 18 (90.0) | 0.212 |
Number of vaccine doses, mean (SD) | 1.52 (1.07) | 2.65 (1.08) | < 0.0001 |
Moderate COVID-19, n (%) | 59 (100) | NA | |
Absolute total white blood cell count/mm3, mean (SD) | 6625.2 (2760.6) | 7204.6 (2312.5) | 0.407 |
Absolute neutrophil blood cell count/mm3, mean (SD) | 4869.1 (2562.7) | 5321.4 (2562.7) | 0.485 |
Absolute lymphocyte blood cell count/mm3, mean (SD) | 988.1 (446.7) | 1371.2 (673.2) | 0.006 |
C-reactive protein, mg/l, median (range) | 18.0 (0.4–261.7) | 3.1 (0.5–28.0) | < 0.0001 |
Procalcitonin, ng/ml, median (range) | 0.82 (0.14–30.40) | 0.23 (0.07–0.39) | < 0.0001 |
Ferritin, ng/ml, median (range) | 720 (27–7430) | 42.5 (5.9–374.3) | < 0.0001 |
Urea, mg/dl mean (SD) | 132.9 (45.4) | 130.4 (30.9) | 0.827 |
Creatinine, mg/dl mean (SD) | 7.34 (2.56) | 8.47 (1.79) | 0.087 |
Medical history of diabetes mellitus, n (%) | 27 (46.6) | 8 (40.0) | 0.795 |
Medical history of arterial hypertension, n (%) | 46 (80.7) | 11 (55.0) | 0.037 |
Obesity, n (%) | 12 (20.7) | 5 (25.0) | 0.756 |